DD Support Board and Research Team

[236T568]

Actually, wrong

PBIO specifically states that the convertible debt was raised between July 23, 2015 and March 31, 2016 at a $0.28/share conversion price

the stock price of PBIO ranged from a low of .20 to a high of .51 during this period, implying a very significant discount of 45% to market price if they were issued when the price was at .51.

So why didn't PBIO show the exactly dates of the convertible financing?

not surprised

and why is this not surprising?

because this is what scam companies do!



http://ih.advfn.com/p.php?pid=nmona&article=71495845

6) Convertible Debt and Other Debt

We entered into Subscription Agreements (the “ Subscription Agreement ”) with various individuals (each, a “ Purchaser ”) between July 23, 2015 and March 31, 2016, pursuant to which the Company sold Senior Secured Convertible Debentures (the “ Debentures ”) and warrants to purchase shares of common stock equal to 50% of the number of shares issuable pursuant to the subscription amount (the “ Warrants ”) for an aggregate purchase price of $6,319,549 (the “ Purchase Price ”).

The Company issued a principal aggregate amount of $6,951,504 in Debentures which includes a 10% original issue discount on the Purchase Price. The Debenture does not accrue any additional interest during the first year it is outstanding but accrues interest at a rate equal to 10% per annum for the second year it is outstanding. The Debenture has a maturity date of two years from issuance. The Debenture is convertible any time after its issuance date. The Purchaser has the right to convert the Debenture into shares of the Company’s common stock at a fixed conversion price equal to $0.28 per share, subject to applicable adjustments. In the second year that the Debenture is outstanding, any interest accrued shall be payable quarterly in either cash or common stock, at the Company’s discretion.